Commonwealth Bank of Australia’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-472
| Closed | -$39K | – | 139 |
|
2019
Q2 | $39K | Buy |
472
+122
| +35% | +$10.1K | ﹤0.01% | 1001 |
|
2019
Q1 | $30K | Hold |
350
| – | – | ﹤0.01% | 998 |
|
2018
Q4 | $29K | Buy |
350
+116
| +50% | +$9.61K | ﹤0.01% | 994 |
|
2018
Q3 | $21K | Sell |
234
-100
| -30% | -$8.97K | ﹤0.01% | 1057 |
|
2018
Q2 | $30K | Buy |
334
+164
| +96% | +$14.7K | ﹤0.01% | 705 |
|
2018
Q1 | $13K | Hold |
170
| – | – | ﹤0.01% | 730 |
|
2017
Q4 | $13K | Sell |
170
-2
| -1% | -$153 | ﹤0.01% | 749 |
|
2017
Q3 | $14K | Sell |
172
-804
| -82% | -$65.4K | ﹤0.01% | 733 |
|
2017
Q2 | $87K | Buy |
976
+172
| +21% | +$15.3K | ﹤0.01% | 732 |
|
2017
Q1 | $70K | Buy |
804
+123
| +18% | +$10.7K | ﹤0.01% | 757 |
|
2016
Q4 | $57K | Sell |
681
-130
| -16% | -$10.9K | ﹤0.01% | 748 |
|
2016
Q3 | $76K | Hold |
811
| – | – | ﹤0.01% | 686 |
|
2016
Q2 | $63K | Sell |
811
-240
| -23% | -$18.6K | ﹤0.01% | 700 |
|
2016
Q1 | $87K | Buy |
1,051
+259
| +33% | +$21.4K | ﹤0.01% | 651 |
|
2015
Q4 | $83K | Buy |
792
+159
| +25% | +$16.7K | ﹤0.01% | 666 |
|
2015
Q3 | $66K | Buy |
633
+208
| +49% | +$21.7K | ﹤0.01% | 695 |
|
2015
Q2 | $58K | Sell |
425
-175
| -29% | -$23.9K | ﹤0.01% | 689 |
|
2015
Q1 | $75K | Sell |
600
-200
| -25% | -$25K | ﹤0.01% | 621 |
|
2014
Q4 | $72K | Sell |
800
-5,000
| -86% | -$450K | ﹤0.01% | 621 |
|
2014
Q3 | $419K | Sell |
5,800
-200
| -3% | -$14.4K | 0.01% | 628 |
|
2014
Q2 | $373K | Sell |
6,000
-49,183
| -89% | -$3.06M | 0.01% | 623 |
|
2014
Q1 | $3.76M | Sell |
55,183
-1,380
| -2% | -$94.1K | 0.02% | 512 |
|
2013
Q4 | $3.98M | Sell |
56,563
-240
| -0.4% | -$16.9K | 0.03% | 480 |
|
2013
Q3 | $4.1M | Sell |
56,803
-5,007
| -8% | -$361K | 0.03% | 441 |
|
2013
Q2 | $3.45M | Buy |
+61,810
| New | +$3.45M | 0.03% | 462 |
|